Korean biotech firm bought by Parataxis for Bitcoin treasury use

Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers.

Related Posts

Leave a Reply

Recent Articles

Norway’s government explores crypto mining ban amid energy supply concerns
June 20, 2025
Bitcoin’s $96B open interest shows role leverage plays in rallies, but there is a risk
June 20, 2025
Crypto Biz: AI money rush could reshape digital asset industry
June 20, 2025

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Post Category